Literature DB >> 7114799

Invasive pattern and phenotypic properties of malignant neurogenic rats cells in vivo and in vitro.

S Mørk, L De Ridder, O D Laerum.   

Abstract

Twelve malignant neurogenic rat cell lines induced by the carcinogen ethylnitrosourea (EtNU) have been investigated for invasiveness in an in vitro three-dimensional culture system. The histological pattern of invasiveness into embryonic chick heart fragments has been compared to the morphology in subcutaneous and intracerebral solid tumours as well as to other phenotypic properties of the cells. In all the cell lines invasiveness was seen both in vivo and in vitro. The site of in vivo transplantation seemed to influence the tumour-host tissue interface, since intracerebral tumours were more sharply delimited than subcutaneous tumours and primary EtNU-induced CNS tumours. The histological patterns in vivo (glioma versus neurinoma-like) were in most cases similar to invasive growth in vitro. The pattern of invasiveness did not correlate to other phenotypic properties of the cells (e.g. ploidy, doubling time, latency for tumour formation and surface microarchitecture). A rat fibroblastic cell line, RE-E was non-tumourigenic in rats and non-invasive in culture, but formed small subcutaneous tumours in nude mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114799

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Mitogens as motogens.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 2.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

3.  Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice.

Authors:  L I de Ridder; O D Laerum; S J Mørk; D D Bigner
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.